| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/27/2008 | EP1961744A1 Basic group-containing compound and use thereof |
| 08/27/2008 | EP1961742A1 compounds of formula (I) as serine protease inhibitors |
| 08/27/2008 | EP1961738A1 New compounds with antiglutamatergic properties and uses thereof |
| 08/27/2008 | EP1961734A1 Amine compound and use thereof for medical purposes |
| 08/27/2008 | EP1961447A2 Treating depressive disorders with PKC activators |
| 08/27/2008 | EP1961422A1 Easily absorbed oral preparation containing xanthine derivative |
| 08/27/2008 | EP1961421A1 Opioids for the treatment of the chronic obstructive pulmonary disease (COPD) |
| 08/27/2008 | EP1961420A1 Agent for prevention and treatment of acute renal failure |
| 08/27/2008 | EP1961419A1 Dosage forms comprising a CETP inhibitor and an HMG-CoA reductase inhibitor |
| 08/27/2008 | EP1961418A1 The use of isothiocyanates compounds in treating prostatic diseases and skin cancer |
| 08/27/2008 | EP1961417A1 Bisoprolol-containing adhesive patch |
| 08/27/2008 | EP1961416A1 Medical use of inhibitors of glutaminyl and glutamate cyclases |
| 08/27/2008 | EP1961413A1 Rapidly disintegratable oral tablet |
| 08/27/2008 | EP1961312A2 Microbial oil mixture and uses thereof |
| 08/27/2008 | EP1961311A1 Food comprising polyunsaturated fatty acids for the prevention of chronic diseases |
| 08/27/2008 | EP1961310A1 Novel use of (-) -epigallocatechin gallate |
| 08/27/2008 | EP1960778A2 Method for demonstrating presence or absence of markers associated with the presence and/or the chemosensitivity of tumors |
| 08/27/2008 | EP1960769A1 Mix for quality control of the medicine "glycine tablets for sublingual applying o.1g." and its preparation method |
| 08/27/2008 | EP1960589A1 Method for finishing textiles with care oils |
| 08/27/2008 | EP1960436A1 Chitin derivatives for hyperlipidemia |
| 08/27/2008 | EP1960417A1 Polymorphs of androgen receptor modulator - (n-3h-imidazo [4 , 5-b] pyridin-2-yl-methyl) -2-fluoro-4-methyl-3-oxo-4-aza-androst- 1-en-17 . beta . -carboxamide |
| 08/27/2008 | EP1960415A2 Phospholipid gel compositions for delivery of aptamers and methods of treating conditions using same |
| 08/27/2008 | EP1960413A2 Macrolides derivatives as antibacterial agents |
| 08/27/2008 | EP1960412A2 Amphotericin b salt |
| 08/27/2008 | EP1960406A2 Ascomycin and pimecrolimus having reduced levels of desmethylascomycin and 32-deoxy-32-epichloro-desmethylascomycin respectively, and methods for preparation thereof |
| 08/27/2008 | EP1960404A1 Substituted aminophenylsulfonamide compounds as hiv protease inhibitor |
| 08/27/2008 | EP1960403A1 Pyrrolotriazine kinase inhibitors |
| 08/27/2008 | EP1960401A1 Tricyclic amide derivatives useful for treating obesity |
| 08/27/2008 | EP1960400A1 Pyrazoloisoquinoline derivatives |
| 08/27/2008 | EP1960399A1 Pyrrolopyridines as kinase inhibitors |
| 08/27/2008 | EP1960398A1 Aryl acetic acid and ester derivatives and their uses as antiinflammatory |
| 08/27/2008 | EP1960397A2 Crystalline forms of palonosetron hydrochloride |
| 08/27/2008 | EP1960396A2 Carbamate compounds as 5-ht4 receptor agonists |
| 08/27/2008 | EP1960395A1 Plasminogen activator inhibitor-1 inhibitors |
| 08/27/2008 | EP1960392A2 Heterocycle-substituted 3-alkyl azetidine derivatives |
| 08/27/2008 | EP1960391A1 Piperazine derivatives and their use in therapy |
| 08/27/2008 | EP1960390A1 Biaryl compounds useful as agonists of the gpr38 receptor |
| 08/27/2008 | EP1960389A2 Compounds which have activity at m1 receptor and their uses in medicine |
| 08/27/2008 | EP1960387A1 Isoquinoline et benzo[h]isoquinoline derivatives, preparation and therapeutic use thereof as antagonists of histamine h3 receptor |
| 08/27/2008 | EP1960386A2 Substituted cycloalkylpyrrolones as allosteric modulators of glucokinase |
| 08/27/2008 | EP1960385A1 Substituted dihydroisoindolones as allosteric modulators of glucokinase |
| 08/27/2008 | EP1960384A1 New process for the preparation of esomeprazole non-salt form |
| 08/27/2008 | EP1960383A1 5-substituted indole-2-carboxamide derivatives |
| 08/27/2008 | EP1960382A1 Heterocyclic compounds as tyrosine kinase modulators |
| 08/27/2008 | EP1960381A1 Aminophenylsulfonamide derivatives as hiv protease inhibitor |
| 08/27/2008 | EP1960380A1 F,g,h,i and k crystal forms of imatinib mesylate |
| 08/27/2008 | EP1960377A1 l , l , 3-TRI0X0-l , 2 , 5-THIADIAZ0LIDINES AND THEIR USE AS PTP-ASES INHIBITORS |
| 08/27/2008 | EP1960376A1 Oxadiazole derivatives with crth2 receptor activity |
| 08/27/2008 | EP1960375A1 Novel macrolide compounds with antibiotic and antneoplastic properties |
| 08/27/2008 | EP1960373A2 Novel quinoxaline derivatives and their medical use |
| 08/27/2008 | EP1960372A1 Kinase inhibitors and their uses |
| 08/27/2008 | EP1960371A1 Quinazoleine derivatives used as inhibitors of erbb tyrosine kinase |
| 08/27/2008 | EP1960370A1 Pyridiazinone derivatives for tumour treatment |
| 08/27/2008 | EP1960369A1 Indanyl-and tetrahydronaphthyl-amino-azoline compounds for combating animal pests |
| 08/27/2008 | EP1960368A1 2,4,5-triphenyl imidazoline derivatives as inhibitors of the interaction between p53 and mdm2 proteins for use as anticancer agents |
| 08/27/2008 | EP1960367A2 Substituted pyrazole compounds useful as soluble epoxide hydrolase inhibitors |
| 08/27/2008 | EP1960366A2 N-substituted indenoisoquinolines and syntheses thereof |
| 08/27/2008 | EP1960365A2 Azonafide derivatives, methods for their production and pharmaceutical compositions therefrom |
| 08/27/2008 | EP1960364A2 Chemical derivatives of jasmonate, pharmaceutical compositions and methods of use thereof |
| 08/27/2008 | EP1960361A1 Pyridylsulfonamide derivatives, their manufacture and use as antineoplastic agents |
| 08/27/2008 | EP1960360A1 Azetidine derivatives as glyt1 inhibitors |
| 08/27/2008 | EP1960359A1 Novel n-sulfamoyl-piperidineamides for the prophylaxis or treatment of obesity and related conditions |
| 08/27/2008 | EP1960358A1 Antineoplastic compounds |
| 08/27/2008 | EP1960356A2 Multivalent indole compounds and use thereof as phospholipase-a2 inhibitors |
| 08/27/2008 | EP1960355A1 3-amino-1-arylpropyl indoles and aza-substituted indoles |
| 08/27/2008 | EP1960354A2 Chemical process for the preparation of an amido-phenoxybenzoic acid compound |
| 08/27/2008 | EP1960353A2 Prostaglandins and analogues as agents for lowering intraocular pressure |
| 08/27/2008 | EP1960351A1 Propionamide compounds as antiinflammatory agents |
| 08/27/2008 | EP1960343A2 Indene derivatives, their preparation and use as medicaments |
| 08/27/2008 | EP1960016A1 Method for extracorporeal removal of a pathogenic microbe, an inflammatory cell or an inflammatory protein from blood |
| 08/27/2008 | EP1959990A2 Pqs and its conjugates as adjuvants and their uses in pharmaceutical compositions |
| 08/27/2008 | EP1959989A2 Cyclic-dinucleotides and its conjugates as adjuvants and their uses in pharmaceutical compositions |
| 08/27/2008 | EP1959981A2 Anti-connexin compounds and therapeutic uses thereof |
| 08/27/2008 | EP1959970A1 Use of a polysaccharide which is excreted by the vibrio dlabolicus species for the regeneration and protection of the periodontium |
| 08/27/2008 | EP1959969A2 Compositions and methods for the treatment or prevention of disorders relating to oxidative stress |
| 08/27/2008 | EP1959968A2 Modulation of the p2y2 receptor pathway |
| 08/27/2008 | EP1959967A2 Inhibitors of histone deacetylase for the treatment of disease |
| 08/27/2008 | EP1959966A2 Ganaxolone formulations and methods for the making and use thereof |
| 08/27/2008 | EP1959965A1 Use of c3-c10 17alfa-esters of 9,11-dehydrocortexolone as anti-gonadotrophic agents |
| 08/27/2008 | EP1959964A1 Heteroaromatic sulfonamide prodrugs |
| 08/27/2008 | EP1959963A2 Certain chemical entities, compositions and methods |
| 08/27/2008 | EP1959962A2 Certain chemical entities, compositions, and methods |
| 08/27/2008 | EP1959961A2 Formulation of insoluble small molecule therapeutics in lipid-based carriers |
| 08/27/2008 | EP1959960A2 Certain chemical entities, compositions and methods |
| 08/27/2008 | EP1959959A2 Morpholine carboxamide prokineticin receptor antagonists |
| 08/27/2008 | EP1959958A1 Integrin-binding small molecules |
| 08/27/2008 | EP1959957A1 Pyrimidylaminobenzamide derivatives for the treatment of neurofibromatosis |
| 08/27/2008 | EP1959956A2 Sinomenine derivatives and preparation and uses thereof |
| 08/27/2008 | EP1959955A2 Method of treating abnormal cell growth |
| 08/27/2008 | EP1959954A2 Compositions and methods for treating cns disorders |
| 08/27/2008 | EP1959953A2 Stabilized pharmaceutical composition of pramipexole and method of preparation thereof |
| 08/27/2008 | EP1959952A2 Chemical synthesis of a highly potent epothilone |
| 08/27/2008 | EP1959951A1 Heteroaryl substituted piperidine derivatives as l-cpt1 inhibitors |
| 08/27/2008 | EP1959950A1 Combination of an immunosuppressant and a ppar gamma agonist for the treatment of an undesirable immune response |
| 08/27/2008 | EP1959949A2 Control of intraocular pressure using alk5 modulation agents |
| 08/27/2008 | EP1959948A2 Levodopa prodrug mesylate, compositions thereof, and uses thereof |
| 08/27/2008 | EP1959947A2 Certain chemical entities, compositions and methods |
| 08/27/2008 | EP1959946A2 Methods of treating ischemic related conditions |
| 08/27/2008 | EP1959945A1 Method for correcting a lipid imbalance in a subject |
| 08/27/2008 | EP1959944A1 A pharmaceutical composition comprising an amide derivative |